STEM
Esperanza Avila Aponte has over 22 years of experience in the pharmaceutical and biotechnology industry. Esperanza is currently serving as the Vice President and General Manager for STEM Healthcare in Brazil and LATAM. In this role, they oversee P&L, sales, marketing, and business development, leading a team of project managers and field consultants. Prior to this, Avila Aponte worked at GlaxoSmithKline Pharma GmbH in various roles, including Marketing and Commercial Director for LATAM and Brazil. Esperanza also led regional teams and was responsible for developing and implementing strategies for both private and public markets. Overall, Avila Aponte has extensive experience in P&L management, marketing, sales, and strategic planning within the pharmaceutical industry.
Esperanza Avila Aponte's education history includes attending Universidad de Los Andes, although no specific dates or degrees are mentioned. Esperanza also studied at Universidad de La Salle and obtained a Master of Science degree in Marketing Management.
This person is not in any offices
STEM
STEM is part of Inizio Advisory, a trusted advisor for pharmaceutical, life science and healthcare companies at every stage of the product and patient journey. Through Advisory’s data driven approach and connected intelligence and solutions, Inizio Advisory helps accelerate clinical and commercial success, creating long term value for clients and their patients. Since 2007, STEM has been helping life science companies optimize the commercial performance by measuring the alignment between their brand strategy and execution at every stage of the product stage of the product lifecycle. We do this through our objective industry insights, robust benchmarking data, and a proven methodology, helping clients to improve return on investment, drive greater customer engagement, accelerate their brands performance and ensure world-class medicines reach the right patients.